BioLineRx Ltd. (BLRX) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biolinerx Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.336 First Quarter 2026 Financial Results Conference Call. 00:00:04.336 -- 00:00:07.440 All participants are presently in a listen-only mode. 00:00:07.440 -- 00:00:11.446 Following management's call and presentation, instructions will be given for the question 00:00:11.446 -- 00:00:16.652 and answer session. For operator assistance during the conference, please press star 00:00:16.652 -- 00:00:22.700 zero. I would now like to turn over the call to Chuck Pallada, Investor Relations. 00:00:22.700 -- 00:00:24.923 Chuck, please go ahead. 00:00:24.923 -- 00:00:28.788 Thank you, Operator, and welcome, everyone, and thank you for joining us on our quarterly 00:00:28.788 -- 00:00:33.960 results conference call. Earlier today, we issued a press release, a copy of which 00:00:33.960 -- 00:00:37.326 is available in the investor relations section of our website. 00:00:37.326 -- 00:00:40.448 It was also filed as a 6K. 00:00:41.052 -- 00:00:47.382 I'd like to remind everyone that certain statements we make during the call will be forward-looking. 00:00:47.382 -- 00:00:52.791 Because such statements deal with future events and are subject to many risks and uncertainties, 00:00:52.791 -- 00:00:58.283 actual results may differ materially from those in the forward-looking statements. 00:00:58.283 -- 00:01:03.388 For a full discussion of these risks and uncertainties, please review our annual report 00:01:03.388 -- 00:01:08.413 on Form 20F and our quarterly reports on Form 6K that are filed with the 00:01:08.413 -- 00:01:11.754 U.S. Securities and Exchange Commission. 00:01:12.357 -- 00:01:15.620 At this time, it is now my pleasure to turn the call over to Mr. 00:01:15.620 -- 00:01:19.682 Phil Serlin, Chief Executive Officer of BylineRx. 00:01:19.824 -- 0...